Emcure Pharmaceuticals Achieves ₹9,204 Cr Revenue Milestone; Targets Margin Growth in FY27
Emcure Pharmaceuticals surpassed the $1 billion revenue milestone in FY26, driven by a 22.2% surge in international markets. While domestic restructuring led to a temporary Q4 slowdown in the Zuventus portfolio, management has guided for margin expansion and steady growth for FY27.
Afcom Holdings Completes ₹199.84 Crore QIP; Allots 26.3 Lakh Shares at ₹759.72
Afcom Holdings Limited has successfully concluded its Qualified Institutions Placement, raising ₹199.84 crore through the issuance of 26,30,520 equity shares. The allotment was finalized on May 05, 2026, at an issue price of ₹759.72 per share to strengthen the company's financial position.
Auro Laboratories Secures EDQM Approval for Metformin Hydrochloride Facility at Tarapur
Auro Laboratories has received a formal Attestation of Inspection from the European Directorate for the Quality of Medicines & Healthcare (EDQM) for its MIDC Tarapur facility. This regulatory milestone confirms the site's compliance with European Union Good Manufacturing Practice (GMP) standards for the production of Metformin Hydrochloride.
Auro Laboratories Secures Swissmedic GMP Compliance for Tarapur Plant; Revenue Up 207%
Auro Laboratories Ltd has secured a Certificate of GMP Compliance from Swissmedic for its manufacturing facility in Tarapur, Maharashtra. This approval validates the plant's adherence to international quality standards under the EU-Switzerland Mutual Recognition Agreement, facilitating entry into regulated European markets.